A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection

Author:

Li Ying12,Yin Yousheng3,Peng Xiaomei4,Zheng Hongguang5,Fu Fajun6,Liu Zhenxiang7,Wu Xiongfei8,Wu Xiaoyan9,Zheng Song10,Chen Nan11,He Leye12,Ren Laicheng13,Ni Zhaohui14,Li Detian15,Liang Peiyu16,Lv Xiaoju17,Zhang Yingyuan12

Affiliation:

1. Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China

2. Key Laboratory of Clinical Pharmacology of Antibiotics, National Health and Family Planning Commission, Shanghai, China

3. Department of Nephrology, The Affiliated Hospital of Guilin Medical College, Guilin, China

4. Department of Urology, People’s Hospital of Guangxi Autonomous Region, Nanning, China

5. Department of Nephrology, General Hospital of Northern Theater Command, Shenyang, China

6. Department of Urology, Changsha Central Hospital, Changsha, China

7. Department of Urology, Haikou People’s Hospital, Haikou, China

8. Department of Nephrology, The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, China

9. Department of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan, China

10. Department of Urology, Union Hospital Affiliated to Fujian Medical University, Fuzhou, China

11. Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

12. Department of Urology, The Third Xiangya Hospital of Central South University, Changsha, China

13. Department of Urology, The Second Hospital of Shanxi Medical University, Taiyuan, China

14. Department of Nephrology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

15. Department of Nephrology, Shengjing Hospital, China Medical University, Shenyang, China

16. Department of Urology, The Affiliated Hospital of Hainan Medical University, Haikou, China

17. Department of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China

Funder

Daiichi Sankyo (China) Holdings Co., Ltd.

Publisher

Informa UK Limited

Subject

General Medicine

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Uropathogenic Escherichia coli infection: innate immune disorder, bladder damage, and Tailin Fang II;Frontiers in Cellular and Infection Microbiology;2024-04-04

2. Novel Antibiotics in Urology;Guide to Antibiotics in Urology;2024

3. Definitions of Urinary Tract Infection in Current Research: A Systematic Review;Open Forum Infectious Diseases;2023-06-27

4. Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity;Frontiers in Microbiology;2022-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3